Lahiji R, Ramacciotti LS, Morton E, Nicaise EH, Braunschweig A, Palmateer G, Schmeusser B, Patil D, Richardson M, Glover F, Kearns E, Lay A, Hajiha M, Master VA, Ogan K. Computerized tomography‐derived body composition metrics are associated with 24‐h urine lithogenic parameters. BJUI Compass. 2026;7(1): e70152. 10.1002/bco2.70152
In Table 1, we noticed an error in the placement of a superscript ‘a’ or ‘b’ in the first column. The corrected table is presented below.
TABLE 1.
Demographics, clinical characteristics and body composition metrics according to sex.
| Covariate | Total (n = 433) | Male (n = 227) | Female (n = 206) | p‐value |
|---|---|---|---|---|
| Age at collection (years) a | 57 (45–66) | 57 (46–68) | 56 (45–65) | 0.09 |
| Volume (L) a | 1.9 (1.4–2.5) | 2.0 (1.5–2.7) | 1.7 (1.2–2.3) | <0.001 |
| SS CaOx a | 5.6 (3.7–8.1) | 5.5 (3.4–8.0) | 5.8 (3.9–8.4) | 0.16 |
| Ca24 (mg/day) a | 164.0 (102.6–241.2) | 174.3 (114.6–241.2) | 152.4 (97.2–242.5) | 0.052 |
| Ox24 (mg/day) a | 34.8 (26.8–45.5) | 38.7 (29.8–48.5) | 31.4 (24.9–40.9) | <0.001 |
| Cit24 (mg/day) a | 498.6 (303.0–733.3) | 491.5 (306.4–751.8) | 543.0 (299.1–731.3) | 0.98 |
| SS CaP a | 0.71 (0.29–1.41) | 0.64 (0.28–1.36) | 0.74 (0.31–1.45) | 0.27 |
| pH a | 6.02 (5.67–6.45) | 6.00 (5.60–6.39) | 6.04 (5.71–6.46) | 0.14 |
| SS UA a | 0.65 (0.23–1.35) | 0.68 (0.27–1.44) | 0.59 (0.20–1.22) | 0.11 |
| UA24 (g/day) a | 0.58 (0.45–0.76) | 0.65 (0.52–0.84) | 0.51 (0.41–0.63) | <0.001 |
| Na24 (mg/day) a | 151.3 (112.4–209.9) | 167.8 (133.8–228.8) | 134.9 (94.9–185.9) | <0.001 |
| Cr24/kg a | 18.97 (15.32–22.69) | 21.33 (17.83–24.29) | 16.24 (13.3–19.73) | <0.001 |
| Days to collection a | 49 (31–73) | 48 (31–72) | 52 (30–78) | 0.75 |
| BMI (kg/m2) a | 27.5 (24.2–32.4) | 28.0 (24.9–31.9) | 27.1 (23.8–33.0) | 0.57 |
| SMI (cm2/m2) a | 50.1 (42.6–57.3) | 55.9 (49.6–61.8) | 44.3 (39.4–49.7) | <0.001 |
| VATI (cm2/m2) a | 53.1 (27.8–80.0) | 65.3 (42.0–88.7) | 38.1 (21.6–64.1) | <0.001 |
| SATI (cm2/m2) a | 76.5 (52.5–111.0) | 63.8 (46.7–88.8) | 97.7 (67.2–131.9) | <0.001 |
| SMD (HU) a | 36.3 (30.2–42.3) | 38.2 (32.2–44.3) | 34.3 (27.2–40.6) | <0.001 |
| ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ | ||||
| Accurate collection b | 376 (86.8) | 180 (87.4) | 196 (86.3) | 0.75 |
| Diabetes b | 83 (19.9) | 50 (22.8) | 33 (16.6) | 0.11 |
| Hypertension b | 189 (45.2) | 113 (51.6) | 76 (38.2) | 0.006 |
| Chronic kidney disease b | 56 (13.4) | 39 (17.8) | 17 (8.5) | 0.005 |
| Gastroesophageal disease b | 111 (26.5) | 54 (24.7) | 57 (28.5) | 0.37 |
| Hyperlipidemia b | 137 (32.7) | 83 (37.9) | 54 (27.0) | 0.02 |
| Antihypertensives medication b | 47 (12.1) | 21 (10.2) | 26 (14.1) | 0.23 |
| Antidiabetic medication b | 101 (25.9) | 56 (27.2) | 45 (24.5) | 0.54 |
| Anti‐hyperlipidaemic medication b | 32 (8.2) | 20 (9.7) | 12 (6.5) | 0.25 |
| Alkalinizing agent b | 39 (10.0) | 27 (13.1) | 12 (6.5) | 0.03 |
| Thiazide diuretics b | 79 (20.3) | 38 (18.5) | 41 (22.3) | 0.35 |
| Charlson comorbidity ≥1 b | 156 (37.3) | 101 (46.1) | 55 (27.6) | <0.001 |
| Race | ||||
| White b | 316 (73.0) | 176 (77.5) | 140 (68.0) | 0.001 |
| Black b | 79 (18.2) | 27 (11.9) | 52 (25.2) | |
| Other b | 38 (8.8) | 24 (10.6) | 14 (6.8) | |
| CaOx primary composition b | 154 (70.7) | 94 (77.0) | 60 (62.5) | 0.005 |
| ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ | ||||
| ≥2 L Urine volume b | 198 (45.7) | 121 (53.3) | 77 (37.4) | 0.001 |
| High SS CaOx (>10) b | 57 (13.2) | 29 (12.8) | 28 (13.6) | 0.8 |
| High Ca24 (M: >250; F > 200; mg/day) b | 121 (27.9) | 53 (23.4) | 68 (33.0) | 0.025 |
| High Ox24 (>40; mg/day) b | 159 (36.7) | 107 (47.1) | 52 (25.2) | <0.001 |
| Low Cit24 (M: <450; F: <550; mg/day) b | 204 (47.1) | 99 (43.6) | 105 (51.0) | 0.13 |
| High SS CaP (>2) b | 54 (12.5) | 22 (9.7) | 32 (15.5) | 0.07 |
| Low pH (<5.8) b | 150 (34.6) | 83 (36.6) | 67 (32.5) | 0.38 |
| High SS UA (>1) b | 161 (37.2) | 92 (40.5) | 69 (33.5) | 0.13 |
| High UA24 (M: >0.8; F: >0.75; g/day) b | 96 (22.2) | 69 (30.4) | 27 (13.1) | <0.001 |
| High Na24 (>150; mg/day) b | 220 (50.8) | 143 (63.0) | 77 (37.4) | <0.001 |
Note: Statistically significant results are emboldened.
Abbreviations: BMI, body mass index; Ca24, calcium per day; CaOx, calcium oxalate; CaP, calcium phosphate; Cit24, citrate per day; Cr24, creatinine per day; Na24, sodium per day; Ox24, oxalate per day; SATI, subcutaneous adipose tissue index; SMD, skeletal muscle density; SMI, skeletal muscle index; SS, supersaturation; UA, uric acid; VATI, visceral adipose tissue index.
Median (IQR).
Number (%).
We apologize for this error.